Study number 8513-406
Dates
Oct 18 2023-Oct 31 2023
Location
Dallas, Texas
Age
18-65
Gender
Both
Compensation
$3,904
Group
G3
The purpose of this study is to evaluate effect of the study drug on how much rosuvastatin (an approved medication treatment of high cholesterol) gets into the blood stream and how long it takes to get rid of it, how well the study drug in combination with rosuvastatin is tolerated and any side effects that may occur.
Fortrea Dallas, TX is recruiting for:
-Healthy Caucasian Adults, age 18-65
-Body Mass Index between 19-32
-Study involves 1 stay of 8 nights & 1 follow-up visit
-Compensation up to $3,904 may be provided for time and participation
-Refer a friend to receive up to $250 per qualified referral
G3:
Check-in: Oct 18
Check-out: Oct 26
Outpatient visit: Oct 31